Will the FDA approve Moderna’s next-gen Covid shot?news2025-05-28T18:35:57+00:00May 28th, 2025|Endpoints News|
FDA leadership preps for summer biopharma listening tour across six citiesnews2025-05-27T18:20:20+00:00May 27th, 2025|Endpoints News|
FDA rejects Savara’s rare lung disease drug over limited manufacturing datanews2025-05-27T17:04:35+00:00May 27th, 2025|Endpoints News|
RFK Jr. ends routine Covid vaccine guidance for kids, pregnant womennews2025-05-27T15:05:19+00:00May 27th, 2025|Endpoints News|
FDA approves Liquidia’s inhaled hypertension drug in two settingsnews2025-05-27T14:47:14+00:00May 27th, 2025|Endpoints News|
Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDAnews2025-05-27T11:24:26+00:00May 27th, 2025|Endpoints News|
About 5% of CBER and CDER left after FDA staff cuts, analysis findsnews2025-05-23T17:33:08+00:00May 23rd, 2025|Endpoints News|
CHMP clears path for GSK’s Blenrep relaunch, recommends four other drugs news2025-05-23T14:53:51+00:00May 23rd, 2025|Endpoints News|
Federal judge blocks RFK Jr. from reorganizing HHSnews2025-05-23T12:37:38+00:00May 23rd, 2025|Endpoints News|
GSK’s Nucala wins COPD approval, stoking rivalry with Dupixent news2025-05-22T21:07:07+00:00May 22nd, 2025|Endpoints News|
